3/19
08:30 am
qnrx
Quoin Pharmaceuticals to Announce Corporate Update and Fourth Quarter and Full-Year 2025 Financial Results on Thursday, March 26, 2026
Medium
Report
Quoin Pharmaceuticals to Announce Corporate Update and Fourth Quarter and Full-Year 2025 Financial Results on Thursday, March 26, 2026
3/11
09:00 am
qnrx
Quoin Pharmaceuticals Announces FDA Grants Fast Track Designation for QRX003 for the Treatment of Netherton Syndrome [Yahoo! Finance]
Medium
Report
Quoin Pharmaceuticals Announces FDA Grants Fast Track Designation for QRX003 for the Treatment of Netherton Syndrome [Yahoo! Finance]
3/11
08:30 am
qnrx
Quoin Pharmaceuticals Announces FDA Grants Fast Track Designation for QRX003 for the Treatment of Netherton Syndrome
Medium
Report
Quoin Pharmaceuticals Announces FDA Grants Fast Track Designation for QRX003 for the Treatment of Netherton Syndrome
2/26
08:54 am
qnrx
NETHERTON NOW Recognizes Rare Disease Day and Highlights Growing Global Awareness of Netherton Syndrome [Yahoo! Finance]
Medium
Report
NETHERTON NOW Recognizes Rare Disease Day and Highlights Growing Global Awareness of Netherton Syndrome [Yahoo! Finance]
2/26
08:30 am
qnrx
NETHERTON NOW Recognizes Rare Disease Day and Highlights Growing Global Awareness of Netherton Syndrome
Medium
Report
NETHERTON NOW Recognizes Rare Disease Day and Highlights Growing Global Awareness of Netherton Syndrome
1/27
08:30 am
qnrx
Quoin Pharmaceuticals Announces Submission to Japanese MHLW for Orphan Drug Designation for QRX003 in Netherton Syndrome
Medium
Report
Quoin Pharmaceuticals Announces Submission to Japanese MHLW for Orphan Drug Designation for QRX003 in Netherton Syndrome
1/20
08:30 am
qnrx
Quoin Pharmaceuticals Files Breakthrough Medicine Designation Application in Saudi Arabia for QRX003 in Netherton Syndrome
Medium
Report
Quoin Pharmaceuticals Files Breakthrough Medicine Designation Application in Saudi Arabia for QRX003 in Netherton Syndrome
3/11
04:32 pm
qnrx
Form 8-K Quoin Pharmaceuticals, For: Mar 11
Medium
Report
Form 8-K Quoin Pharmaceuticals, For: Mar 11
2/17
08:15 pm
qnrx
Form SCHEDULE 13G Quoin Pharmaceuticals, Filed by: ADAR1 Capital Management, LLC
Medium
Report
Form SCHEDULE 13G Quoin Pharmaceuticals, Filed by: ADAR1 Capital Management, LLC
2/17
03:20 pm
qnrx
Form SCHEDULE 13G Quoin Pharmaceuticals, Filed by: Woodline Partners LP
Medium
Report
Form SCHEDULE 13G Quoin Pharmaceuticals, Filed by: Woodline Partners LP
2/11
05:11 pm
qnrx
Form SCHEDULE 13G/A Quoin Pharmaceuticals, Filed by: INTEGRATED CORE STRATEGIES (US) LLC
Medium
Report
Form SCHEDULE 13G/A Quoin Pharmaceuticals, Filed by: INTEGRATED CORE STRATEGIES (US) LLC
2/6
05:29 pm
qnrx
Form SCHEDULE 13G/A Quoin Pharmaceuticals, Filed by: Ikarian Capital, LLC
Low
Report
Form SCHEDULE 13G/A Quoin Pharmaceuticals, Filed by: Ikarian Capital, LLC
2/6
05:24 pm
qnrx
Form 4 Quoin Pharmaceuticals, For: Feb 04 Filed by: Lawlor Sally Bridget
Low
Report
Form 4 Quoin Pharmaceuticals, For: Feb 04 Filed by: Lawlor Sally Bridget
2/6
05:22 pm
qnrx
Form 4 Quoin Pharmaceuticals, For: Feb 04 Filed by: Cooper Joseph Patrick
Low
Report
Form 4 Quoin Pharmaceuticals, For: Feb 04 Filed by: Cooper Joseph Patrick
2/6
05:20 pm
qnrx
Form 4 Quoin Pharmaceuticals, For: Feb 04 Filed by: Culverwell Anthony James
Low
Report
Form 4 Quoin Pharmaceuticals, For: Feb 04 Filed by: Culverwell Anthony James
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register